Cargando…

Gut Microbiome in Probable Intestinal Tuberculosis and Changes following Anti-Tuberculosis Treatment

PURPOSE: Information on the gut microbiome in patients with intestinal tuberculosis (ITB) and changes therein following anti-tuberculosis treatment (ATT) is lacking. We aimed to elucidate differences in stool microbiome between ITB patients and controls and to evaluate stool microbiome changes after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Hyuk, Park, Young Soo, Shin, Cheol Min, Kim, Nayoung, Lee, Dong Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688367/ https://www.ncbi.nlm.nih.gov/pubmed/34913282 http://dx.doi.org/10.3349/ymj.2022.63.1.34

Ejemplares similares

Analysis of the gut microbiome using extracellular vesicles in the urine of patients with colorectal cancer
por: Yoon, Hyuk, et al.
Publicado: (2023)

Contributions of the microbiome to intestinal inflammation in a gut-on-a-chip
por: Jeon, Min Seo, et al.
Publicado: (2022)

Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls
por: Heo, Min, et al.
Publicado: (2023)

Secondary Lymphedema After Intestinal Tuberculosis: A Case Report
por: Hong, Ji Won, et al.
Publicado: (2019)

Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial
por: Yoon, Hyuk, et al.
Publicado: (2015)

Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients
por: Lee, Sun Min, et al.
Publicado: (2021)

Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study
por: Shi, Wenpei, et al.
Publicado: (2019)

The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
por: Eribo, Osagie A., et al.
Publicado: (2019)

Alterations in the Gut Microbiome of Individuals With Tuberculosis of Different Disease States
por: Wang, Yue, et al.
Publicado: (2022)

The gut microbiome: A line of defense against tuberculosis development
por: Yu, Ziqi, et al.
Publicado: (2023)

Total polyp number may be more important than size and histology of polyps for prediction of metachronous high-risk colorectal neoplasms
por: Yoon, Hyuk, et al.
Publicado: (2022)

Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment
por: Cao, Demin, et al.
Publicado: (2021)

Anti–PD-L1 Antibody and/or 17β-Estradiol Treatment Induces Changes in the Gut Microbiome in MC38 Colon Tumor Model
por: Song, Chin-Hee, et al.
Publicado: (2023)

Dynamic Changes in Helicobacter pylori Status Following Gastric Cancer Surgery
por: Yoon, Kichul, et al.
Publicado: (2017)

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease
por: Park, Jihye, et al.
Publicado: (2020)

Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study
por: Park, Jihye, et al.
Publicado: (2022)

The Probable Mechanism of Streptomycin Action in Tuberculosis
por: Corper, H. J., et al.
Publicado: (1949)

The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients
por: Hu, Yongfei, et al.
Publicado: (2019)

The microbiome and the gut-lung axis in tuberculosis: interplay in the course of disease and treatment
por: Alvarado-Peña, Néstor, et al.
Publicado: (2023)

Fecal Microbiota and Gut Microbe-Derived Extracellular Vesicles in Colorectal Cancer
por: Park, Jihye, et al.
Publicado: (2021)

Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study
por: Cho, Jae Ho, et al.
Publicado: (2020)

Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial
por: Cho, Jae Ho, et al.
Publicado: (2020)

Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy
por: Bespyatykh, Julia, et al.
Publicado: (2020)

Correlation between Endoscopic and Histological Diagnoses of Gastric Intestinal Metaplasia
por: Lim, Ji Hwan, et al.
Publicado: (2013)

Intestinal Tuberculosis
por: DuMortier, J. J.
Publicado: (1931)

Intestinal Tuberculosis
Publicado: (1901)

Intestinal Tuberculosis
por: Caird, F. M.
Publicado: (1921)

Intestinal Tuberculosis
por: Shrikhande, Y. G.
Publicado: (1936)

Intestinal Tuberculosis
por: Chowdhury, A. Roy
Publicado: (1936)

Intestinal Tuberculosis
por: Shrikhande, Y. G.
Publicado: (1936)

Intestinal Tuberculosis
Publicado: (1931)

Intestinal Tuberculosis
por: Caird, F. M.
Publicado: (1922)

Tuberculosis of the Intestine
por: Stewart, D. A.
Publicado: (1923)

Intestinal Tuberculosis
Publicado: (1913)

Comparisons of Gut Microbiota Among Healthy Control, Patients With Conventional Adenoma, Sessile Serrated Adenoma, and Colorectal Cancer
por: Yoon, Hyuk, et al.
Publicado: (2017)

Hypersensitivity reactions to multiple anti-tuberculosis drugs
por: Shin, Hong-Joon, et al.
Publicado: (2021)

Comparison of loss of response between anti-tumor necrosis factor alone and combined use with immunomodulators in patients with inflammatory bowel disease
por: Hong, Seung Wook, et al.
Publicado: (2021)

Changes in Gut Microbiome upon Orchiectomy and Testosterone Administration in AOM/DSS-Induced Colon Cancer Mouse Model
por: Song, Chin-Hee, et al.
Publicado: (2023)

The Effects of Helicobacter pylori Eradication Therapy for Chronic Idiopathic Thrombocytopenic Purpura
por: Hwang, Jae Jin, et al.
Publicado: (2016)

Is Atrial Fibrillation a Risk Factor for Gastroesophageal Reflux Disease Occurrence?
por: Hwang, Jae Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rt9mr0o190ltjhp3eo7fg70mjr